University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 11 of 26
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
NCT03923556
Bicarbonate Administration and Cognitive Function in Midlife and Older Adults With CKD
NCT04600323
The Geriatric Acute & Post-acute Care Coordination Program for Fall Prevention in the Emergency Department II
NCT04304495
Physiological Mechanisms of Therapeutic Horseback Riding Intervention Effects in a Psychiatric Population of ASD Youth
NCT04606966
Rapid Start vs. Standard Start Antiretroviral Therapy (ART) in HIV
NCT04249037
Predictors of Recovery and the App-Facilitated Tele-Rehabilitation (AFTER) Program for COVID-19 Survivors
NCT04663945
Leveraging Machine Learning to Effortlessly Track Patient Movement in the Clinic.
NCT04074772
Better Together: an Online Physician Coaching Program for Medical Trainees
NCT05280964
Sexual Health in Breast Cancer Patients
NCT05138510
Compensatory Reserve Index (CRI) for Management of COVID-19
NCT04457817
Intervention to Educate and Improve Underrepresented Populations' Participation in Clinical Trials
NCT04863092
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma
NCT04508647
Brigatinib Before Brain Irradiation Trial (B3i Trial)
NCT04634110
Treatment Phenotypes for Adolescents With Asthma
NCT04228107
RRT for PTSD Symptoms in Survivors of Sexual Violence
NCT04073004
PErfusioN, OxyGen ConsUmptIon and ENergetics in ADPKD (PENGUIN)
NCT04407481
Temodar Plus Tyrosine Kinase Inhibitors for Progressive CNS Disease
NCT04541407
The Effects of IV vs Oral Dexamethasone on Postoperative Nausea, Vomiting, and Pain
NCT04563494
Long-acting Biomedical HIV Prevention in Transgender Women
NCT03856580
Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy Balance
NCT04495348
Tofacitinib for Immune Skin Conditions in Down Syndrome
NCT04246372
Shoulder Contraceptive Implant Study
NCT04463693
Proximal Resistance Training for People With Multiple Sclerosis
NCT04548154
Prosperando: Fostering Resilience on Dialysis
NCT03978806
Pilot Trial of Hypnosis and Enhanced Communication In Patients Undergoing MRI
NCT04520100
Effect of CRRT Duration on Solute Removal
NCT04458571
ALIGN Intervention in Patients With Advanced Cancer Discharging to a SNF
NCT04882111
Rifampin and the Contraceptive Implant
NCT04463680
My Baby My Move A Community Wellness Intervention
NCT04294095
The ROUTT-B (Reduce Over-Utilized Tests and Treatments in Bronchiolitis) Study
NCT04302207
Validation of a Portable Indirect Calorimeter
NCT04469452
Novel Approaches for Quantitative Assessment of Adherence
NCT04535934
MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes
NCT03624062
Cancer Patient Perspectives During COVID-19
NCT05062538
RCT Implant Based Breast Reconstruction
NCT04558138
Safety Education in the Emergency Department: A Pilot Study
NCT05168878
In-Utero Vascular Accidents in Neonates From COVID-19 Infected Mothers
NCT04431869
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
NCT04474392
The Use of Ultrasound in Establishing COVID-19 Infection as Part of a Trauma Evaluation
NCT04340479
Persistence of Protection by Shingrix
NCT04169009
A Novel Patient Decision Aid for Surrogate Decision Makers of Comatose Survivors of Cardiac Arrest
NCT03908346
Study of Feasibility and Safety of UCD19 Chimeric Antigen Receptor (CAR) T Cells in Adult Subjects With Relapsed/Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (B-NHL)
NCT04240808
Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking Cessation
NCT04897568
Cardiac Effects From Radiation Therapy by MRI
NCT04486573
Best Practice Alert for Opioid Prescribing
NCT04446975
Lung Ultrasound Implementation in the Management of Patients Hospitalized With COVID-19
NCT04542421
Surgical Telemedicine in the COVID-19 Pandemic Era
NCT04376710
Stress Related Disorders in Family Members of COVID-19 Patients Admitted to the ICU
NCT04476914
Effects of Pecan Nut Snacks v Equicaloric Snacks on Appetite, Food Intake, Metabolism, Hormones and Biomarkers
NCT04484974
Sensor Augmented Pump (SAP) Therapy for Inpatient CFRD Management
NCT03939065
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.